NIKOLA CORP (NKLA)

US6541101050 - Common Stock

0.6353  +0 (+0.76%)

Premarket: 0.6559 +0.02 (+3.24%)

Fundamental Rating

2

NKLA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. Both the profitability and financial health of NKLA have multiple concerns. NKLA is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year NKLA has reported negative net income.
In the past year NKLA has reported a negative cash flow from operations.
NKLA had negative earnings in 4 of the past 5 years.
In the past 5 years NKLA always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -75.79%, NKLA is doing worse than 90.70% of the companies in the same industry.
NKLA's Return On Equity of -134.36% is on the low side compared to the rest of the industry. NKLA is outperformed by 90.70% of its industry peers.
Industry RankSector Rank
ROA -75.79%
ROE -134.36%
ROIC N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NKLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NKLA has more shares outstanding
Compared to 5 years ago, NKLA has more shares outstanding
Compared to 1 year ago, NKLA has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.81, we must say that NKLA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NKLA (-3.81) is worse than 87.60% of its industry peers.
NKLA has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
NKLA's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. NKLA outperforms 55.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -3.81
ROIC/WACCN/A
WACC8.84%

2.3 Liquidity

A Current Ratio of 2.16 indicates that NKLA has no problem at all paying its short term obligations.
With a Current ratio value of 2.16, NKLA perfoms like the industry average, outperforming 50.39% of the companies in the same industry.
NKLA has a Quick Ratio of 1.92. This is a normal value and indicates that NKLA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.92, NKLA is doing good in the industry, outperforming 76.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.92

6

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.62%, which is quite impressive.
Looking at the last year, NKLA shows a very negative growth in Revenue. The Revenue has decreased by -28.61% in the last year.
The Revenue has been growing by 610.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q70.27%
Revenue 1Y (TTM)-28.61%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Revenue growth Q2Q75.79%

3.2 Future

NKLA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.54% yearly.
Based on estimates for the next years, NKLA will show a very strong growth in Revenue. The Revenue will grow by 158.27% on average per year.
EPS Next Y52.67%
EPS Next 2Y27.95%
EPS Next 3Y22.54%
EPS Next 5Y15.54%
Revenue Next Year344.38%
Revenue Next 2Y256.48%
Revenue Next 3Y228.78%
Revenue Next 5Y158.27%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

NKLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NKLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NKLA's earnings are expected to grow with 22.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.95%
EPS Next 3Y22.54%

0

5. Dividend

5.1 Amount

No dividends for NKLA!.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (4/23/2024, 9:21:06 PM)

Premarket: 0.6559 +0.02 (+3.24%)

0.6353

+0 (+0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap848.52M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.79%
ROE -134.36%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.16
Quick Ratio 1.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y52.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-28.61%
Revenue growth 3Y610.32%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y